Dr. Dipanjan Panda

About Dr. Dipanjan Panda

Dr. Dipanjan Panda is a distinguished medical oncologist in India, with over a decade of specialised experience. He is highly regarded for his expertise in treating rare and complex cancers, particularly sarcomas of the soft tissue and bone, gastrointestinal stromal tumours (GIST), and hepatocellular carcinoma (liver cancer). Dr. Panda is an accomplished academic with numerous publications in prestigious international journals and has been an invited expert on national task forces for liver cancer. His approach combines cutting-edge medical treatment with a profound commitment to patient education and empathetic care, making him a trusted and leading oncologist in Delhi for patients seeking comprehensive and personalised cancer treatment.

OPD Schedule Of Dr. Dipanjan Panda

Consultation Fees Rs. 2000 /-

Indraprastha Apollo Hospital, New Delhi

MON 10:00 AM - 05:00 PM

TUE 10:00 AM - 05:00 PM

WED 10:00 AM - 05:00 PM

THU 10:00 AM - 05:00 PM

FRI 10:00 AM - 05:00 PM

SAT 10:00 AM - 05:00 PM

Medical Degrees

DM (Medical Oncology)
MD (Internal Medicine)
MBBS

Major Cancer Types Treated

Sarcomas: Soft Tissue Sarcoma, Bone Sarcoma, Gastrointestinal Stromal Tumour (GIST), Chordoma
Gastrointestinal Cancers: Hepatocellular Carcinoma (Liver Cancer), Gallbladder Cancer, Pancreatic Cancer, Gastric Cancer.
Haematological Malignancies: Acute Lymphoblastic Leukaemia, Hairy Cell Leukaemia, Multiple Myeloma.
Other Solid Tumours: Ovarian Cancer, Renal Cell Carcinoma, Malignant Melanoma.

Sub-specialties

Management of rare tumours like Desmoid Tumour and Giant Cell Tumour of bone.
Supportive care for advanced-stage cancers.
Paediatric Myelodysplastic Syndrome.

Advanced Procedures Performed

Systemic Chemotherapy
Targeted Therapy
Immunotherapy
Management of prothrombotic complications in cancer patients.
Personalised treatment planning based on tumour biology.

Current & Past Hospital Affiliations

Medical Oncologist: Apollo Hospitals, Indraprastha, New Delhi (Current)

Academic & Research Roles

Invited Expert Member: INASL Task Force on Hepatocellular Carcinoma (2013).
Invited Expert Member: Advisory Committee Meeting on HCC, Bayer Oncology (2013).

Key Achievements & Contributions

Extensive research and publications on gallbladder cancer, neuroendocrine tumours, and hepatocellular carcinoma, contributing significantly to the understanding of these cancers in the Indian population.
Recognised as a key opinion leader in liver cancer, having served on national consensus panels.
A prolific researcher with over 20 publications in high-impact national and international journals.

Academic Awards

First Certificate of Honour in Medicine and Obstetrics & Gynaecology (3rd Professional MBBS).
Awarded College Scholarship on merit.

Recognitions & Honors

Member of the European Society of Medical Oncology (ESMO).
Member of the American Society of Clinical Oncology (ASCO).

Published Papers in Medical Journals

The INASL Task-Force on Hepatocellular Carcinoma... The Puri Recommendations. - Journal of Clinical and Experimental Hepatology (2014)
Supportive Measures and Finer Practice Points in 177Lu-DOTATATE PRRT for NET... - The Journal of Nuclear Medicine (2014)
Gall bladder cancer and the role of dietary and lifestyle factors... - European Journal of Cancer Prevention (2013)
Prothrombotic profile in multiple myeloma: Response to treatment and associated thrombotic complications... - Journal of Clinical Oncology, ASCO Proceedings (2013)
Gastroenteropancreatic (GEP) Neuroendocrine Tumors, Epidemiology and clinical retrospective study... - 10th Annual conference of ENETS, Barcelona (2013)
Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma... - National Medical Journal of India (2010)

"Finding a doctor who understands rare cancers is difficult. Dr. Dipanjan Panda was a godsend when I was diagnosed with a GIST. His knowledge about the specific targeted therapies for my condition was incredible. He is not just a doctor but a researcher who brings the latest science to his patients. I am doing very well today, thanks to his expert care."
"My father was diagnosed with liver cancer, and we were completely lost. Dr. Panda’s calm and empathetic approach immediately put us at ease. He explained the treatment options clearly and managed my father’s care with exceptional skill. His involvement in national liver cancer guidelines gave us immense confidence. We highly recommend him."

Patient-Centred Care: Dr. Panda is renowned for his empathetic and meticulous approach to patient care. He strongly believes in patient education, dedicating time to help individuals and their families understand the complexities of their diagnosis and treatment options. This collaborative approach empowers patients to be active participants in their healing journey.
Technology & Innovation: As an academic oncologist and a member of prestigious societies like ASCO and ESMO, Dr. Panda remains at the forefront of oncological innovation. He integrates the latest evidence-based methodologies and therapeutic approaches into his practice, with a special focus on sarcomas and hepatocellular carcinoma, ensuring his patients receive care that is both advanced and personalised.

The cost of cancer treatment varies widely based on the diagnosis, the specific drugs required, and the duration of therapy. Below are estimated costs for treatments of conditions managed by Dr. Panda.

Treatment / Procedure	Estimated Cost per Cycle (INR)	Estimated Cost per Cycle (USD)
Chemotherapy for Sarcoma/GI Cancers	₹ 40,000 - ₹ 1,50,000+	$ 480 - $ 1,800+
Targeted Therapy (e.g., for GIST)	₹ 1,00,000 - ₹ 3,00,000+	$ 1,200 - $ 3,600+
Treatment for Liver Cancer (HCC)	Varies widely based on stage and modality	Varies
Immunotherapy	₹ 1,50,000 - ₹ 4,00,000+	$ 1,800 - $ 4,800+

Note: The above costs are estimates. The final cost depends on the specific drugs, treatment duration, and supportive care. The Cancer Rounds team can provide a detailed cost estimate after a medical evaluation.

Language Support: The Cancer Rounds team offers professional interpretation services to ensure seamless communication for international patients during their consultations and treatment with Dr. Panda at Apollo Hospitals.
Visa & Travel Assistance: Our team provides comprehensive assistance with medical visa invitation letters, travel arrangements, airport transfers, and booking accommodation near the hospital in Delhi.
Pre-treatment Virtual Consultations: We facilitate online video consultations with Dr. Dipanjan Panda for international patients. This allows for a review of medical reports, a preliminary opinion on the diagnosis, and a discussion of the potential treatment plan before travelling to India.

Frequently Asked Questions

Dr. Dipanjan Panda is a top Medical Oncologist in India with special interests and deep expertise in treating rare and complex tumours, particularly sarcomas of the soft tissue and bone, gastrointestinal stromal tumours (GIST), and hepatocellular carcinoma (liver cancer).

Dr. Panda has been an invited expert member on the national INASL task force for Hepatocellular Carcinoma (HCC) and has published significant research on the topic. His involvement in formulating national consensus guidelines makes him a leading authority on liver cancer treatment in India.

Sarcomas are rare cancers that arise from the connective tissues of the body, such as bone, muscle, and fat. A Gastrointestinal Stromal Tumour (GIST) is a specific type of sarcoma that occurs in the digestive tract. Dr. Panda has a special interest and extensive experience in managing these complex cancers.

Yes, Dr. Panda is a highly active academic oncologist. He has authored and co-authored over 20 research papers and abstracts in prestigious national and international journals, including the Journal of Clinical Oncology (ASCO) and the European Journal of Cancer Prevention.

To book a consultation with Dr. Panda, you can contact the Cancer Rounds team. They will assist you with scheduling an in-person or virtual appointment and manage all related arrangements.